BiotechTube

Pristiq + Placebo

ApprovedCompleted
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Social Anxiety Disorder

Conditions

Social Anxiety Disorder

Trial Timeline

Apr 1, 2011 → Dec 1, 2012

NCT ID
NCT01316302

About Pristiq + Placebo

Pristiq + Placebo is a approved stage product being developed by Pfizer for Social Anxiety Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT01316302. Target conditions include Social Anxiety Disorder.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01316302ApprovedCompleted

Competing Products

20 competing products in Social Anxiety Disorder

See all competitors
ProductCompanyStageHype Score
LY686017 + paroxetine + placeboEli LillyPhase 2
52
atomoxetine + placeboEli LillyPhase 2/3
65
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
52
Cariprazine + PlaceboAbbVieApproved
85
QuetiapineAstraZenecaApproved
85
quetiapineAstraZenecaPhase 3
77
quetiapineAstraZenecaPhase 2/3
65
Seroquel + Sugar PillAstraZenecaPhase 3
77
quetiapineAstraZenecaApproved
85
Venlafaxine ERPfizerPhase 3
76
Ziprasidone + SertralinePfizerPhase 2
51
Sertraline + PlaceboPfizerApproved
84
NefazodoneBristol Myers SquibbApproved
84
EscitalopramLundbeckApproved
82
Cipralex + PlaceboLundbeckPhase 2
49
BHV-0223 + PlaceboBiohavenPhase 2/3
60
VQW-765 + PlaceboVanda PharmaceuticalsPhase 3
69
PH94BVistagen TherapeuticsPhase 3
69
Fasedienol Nasal Spray - Placebo Nasal Spray + Fasedienol Nasal Spray - Fasedienol Nasal Spray + Placebo Nasal Spray - Placebo Nasal SprayVistagen TherapeuticsPhase 2
44
PH94B Nasal Spray + Placebo Nasal SprayVistagen TherapeuticsPhase 3
69

Other Products from Pfizer

MeropenemApproved
84
celecoxibApproved
84
13vPnCApproved
84
EtanerceptApproved
84
AtorvastatinApproved
84